NovoFy is built to design minibinders for the most difficult targets: the novel epitopes, the GPCRs, and the immunization-impossibles
NovoFy is built to design minibinders for the most difficult targets: the novel epitopes, the GPCRs, and the immunization-impossibles. Through NovoFlow, we design, screen, and validate generated designs at the bench, as either therapeutic candidates or critical reagents.